Immunologic evaluation of environmental lung disease

A. M. Ditto, L. C. Grammer*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Environmental lung disease is any respiratory ailment that results from inhalation of airborne substances, either particulate or gaseous. Some forms of environmental lung disease such as reactive airways dysfunction syndrome are not immunologically mediated, and no immunologic workup is indicated. However, if a patient has a history compatible with an immunologically mediated disease such as asthma or hypersensitivity pneumonitis, appropriate immunologic evaluation should be performed. With the identification, preparation, and characterization of the putative antigen(s), a variety of tests can be used to evaluate the immune mechanism. However, these tests are corroborative only and are to be used in conjunction with a compatible clinical history and other appropriate clinical evaluations such as pulmonary function tests and chest films. Once a diagnosis is established, corticosteroids or other medications may be useful in the management of the acute disease, but the definitive treatment is avoidance of the antigen.

Original languageEnglish (US)
Pages (from-to)276-285
Number of pages10
JournalClinical Pulmonary Medicine
Issue number5
StatePublished - 1995


  • Asthma
  • Environmental
  • Hypersensitivity pneumonitis
  • Immunologic
  • Respiratory

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Immunologic evaluation of environmental lung disease'. Together they form a unique fingerprint.

Cite this